The Clinical Efficacy of Minimally Invasive Clamp-Assisted Reduction and Open Reduction with Wire Cerclage for Unstable Subtrochanteric Fractures

Table 1

Baseline characteristics and clinical outcomes of Group A and Group B.

	Group A (n = 41), %	Group B (n = 27), %	value
Sex (male)	30 (73.17)	19 (70.37)	0.80
Age (y)	58.98 (31–83)	57.04 (30–83)	0.65
Seinsheimer classification			0.76
IIB	13 (31.71)	8 (29.63)	1.00
IIC	2 (4.87)	1 (3.70)	1.00
IIIA	11 (26.83)	4 (14.81)	0.37
IIIB	1 (2.44)	2 (7.41)	0.56
IV	9 (21.95)	7 (25.93)	0.77
V	5 (12.20)	5 (18.52)	0.50
Quality of reduction			0.03
Good	24 (58.54)	22 (81.48)
Acceptable	12 (29.27)	5 (18.52)
Poor	5 (12.20)	0
Implant type			0.94
Gamma3	12 (29.27)	9 (33.33)
InterTan	8 (19.51)	5 (18.52)
PFN	21 (51.22)	13 (48.15)
Operation time (min)	102.05 ± 29.04	124.01 ± 35.28	0.04
Estimated-blood-loss (ml)	145.73 ± 75.50	172.59 ± 83.79	0.12
Complication rate	3 (7.32)	2 (7.41)	0.86
Nonunion	2	0
Infection	1	1
Cut-out	0	1
TAD (cm)	20.34 ± 4.38	21.11 ± 3.21	0.33
Varus/valgus	126.46 ± 2.89	127.44 ± 2.08	0.83
Follow-up time (months)	17.58 ± 4.58	19.44 ± 5.53	0.16
Day of stay (days)	8.22 ± 1.97	9.52 ± 2.01	0.08
Union time (months)	4.82 ± 0.89	3.56 ± 0.64	0.01
HHS	76.29 ± 9.27	75.59 ± 8.88	0.64